NUCYNTA ER Drug Profile, 2024: NUCYNTA ER (tapentadol hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

by DrugPatentWatch

NUCYNTA ER Drug Profile, 2024

This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:

United States patentsExpired United States patentsFDA Paragraph IV patent challengesDistrict Court patent litigationPatent Trial and Appeal Board (PTAB) patent casesEuropean supplementary protection certificates (SPCs)Clinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesFREE...

• Format: Paperback
• Language: English
• ISBN: B0CS3F61WN
• ISBN13: 9798875720017
• Release Date: January 2024
• Publisher: Independently Published
• Length: 144 Pages
• Weight: 0.77 lbs.
• Dimensions: 0.3" x 8.5" x 11.0"